Your Health, We Care
The most common adverse reactions (≥ 20%) were fatigue, constipation,dysgeusia, edema, dizziness, diarrhea, nausea, dysesthesia, dyspnea, myalgia,cognitive impairment, increased weight, cough, vomiting, pyrexia, arthralgia, and vision disorders.
from FDA，2024.01
Entrectinib is a targeted anticancer drug primarily used to treat solid tumors a···【more】
Release date：2026-03-09Recommended：11
